| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.064 | 0.2 |